Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis

Journal of the Neurological Sciences
Edgar MeinlReinhard Hohlfeld

Abstract

In multiple sclerosis (MS) the CNS is not only the target of the pathological immune response, but the CNS itself becomes an immunological compartment during the course of the disease. This comprises (i) inflammation beyond classical white matter lesions, (ii) intrathecal Ig production with oligoclonal bands, (iii) an environment fostering immune cell persistence, (iv) follicle-like aggregates in the meninges, (v) a disruption of the blood-brain barrier also outside of active lesions, which allows influx of autoantibodies possibly promoting demyelination or axonal injury and influx of fibrinogen driving inflammation.

References

Jan 1, 1986·The Journal of Experimental Medicine·M J Walsh, W W Tourtellotte
Feb 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·E J ThompsonP Rudge
Mar 4, 1998·Annals of Neurology·G P OwensD H Gilden
Jan 11, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T L SørensenR M Ransohoff
Jul 17, 2003·The Journal of Clinical Investigation·Danielle T AveryStuart G Tangye
Jul 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anna CorcioneVito Pistoia
Mar 18, 2005·Annual Review of Immunology·Rudolf A ManzAndreas Radbruch
Apr 1, 2005·Brain : a Journal of Neurology·Sabine CepokBernhard Hemmer
May 12, 2005·Current Opinion in Immunology·Pascal Schneider
Oct 19, 2005·Brain : a Journal of Neurology·Alexandra KutzelniggHans Lassmann
Feb 10, 2006·The New England Journal of Medicine·Israel F Charo, Richard M Ransohoff
Sep 8, 2006·Journal of Neuropathology and Experimental Neurology·Sonja HochmeisterHans Lassmann
Dec 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Dun ZhouBernhard Hemmer
Jan 24, 2007·Nature Medicine·Kevin C O'ConnorKai W Wucherpfennig
May 12, 2007·Brain Pathology·Alexandra KutzelniggHans Lassmann
Sep 12, 2007·The Journal of Experimental Medicine·Emily K MatheyChristopher Linington
Sep 25, 2007·Brain : a Journal of Neurology·Andreas JunkerKlaus Dornmair
Nov 7, 2007·The Journal of Experimental Medicine·Barbara SerafiniFrancesca Aloisi

❮ Previous
Next ❯

Citations

Jun 1, 2011·Acta Neuropathologica·Richard ReynoldsOwain Howell
Apr 3, 2009·Brain : a Journal of Neurology·Josa M FrischerHans Lassmann
Jun 11, 2010·Brain : a Journal of Neurology·Antonio ScalfariGeorge C Ebers
Aug 16, 2011·Brain : a Journal of Neurology·Owain W HowellRichard Reynolds
Mar 6, 2016·Journal of Neuroimmunology·Joachim Burman, Anders Svenningsson
Aug 12, 2015·Seminars in Immunopathology·Luke M HealyJack P Antel
Apr 20, 2016·Frontiers in Immunology·Ferdinand Jagot, Nathalie Davoust
Jan 15, 2014·Medical Hypotheses·Mickael Bonnan
Oct 22, 2010·Journal of Neuroimmunology·Andrew R PachnerDavid Lagunoff
Oct 30, 2016·Brain Pathology·Markus KippSandra Amor
Sep 26, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Giancarlo Comi
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Mixalis L Kosmidis, Marinos C Dalakas
Mar 9, 2018·Annals of Neurology·Roberta MagliozziMassimiliano Calabrese
Jan 7, 2015·British Journal of Community Nursing·Karen Strickland, Fiona Baguley
Oct 20, 2018·Diabetes/metabolism Research and Reviews·Shihab KochumonRasheed Ahmad
Oct 19, 2019·Current Treatment Options in Neurology·Anastasie M Dunn-PirioRevere P Kinkel
Nov 13, 2019·Nature Reviews. Neuroscience·Joseph J SabatinoScott S Zamvil
Apr 27, 2011·Current Opinion in Neurology·Andrew R Pachner
Nov 6, 2015·Frontiers in Neuroscience·Norbert MüllerMarkus J Schwarz
Aug 12, 2020·JCI Insight·Smadar GoldfarbTamir Ben-Hur
Mar 14, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Alice MariottiniPaolo A Muraro
Dec 15, 2016·Frontiers in Immunology·Sara De BiasiAndrea Cossarizza
Aug 11, 2017·PloS One·Ahmed AbdelhakHayrettin Tumani
Dec 29, 2020·Frontiers in Neurology·Austin NegronThomas G Forsthuber
Apr 21, 2021·Brain : a Journal of Neurology·Matteo PardiniDeclan T Chard
May 15, 2021·Brain, Behavior, and Immunity·Smadar GoldfarbTamir Ben-Hur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.